Fluorous-tethered quenching reagents for solution phase parallel synthesis
作者:Craig W. Lindsley、Zhijian Zhao、William H. Leister
DOI:10.1016/s0040-4039(02)00748-7
日期:2002.6
Commercially available fluorous-tethered reagents are employed to quench excess reactants and remove known impurities from crude reaction mixtures generated via solutionphaseparallelsynthesis. Fluorous quenching reagents are expediently removed via FluoroFlash™ SPE columns to afford products in high yields and purities.
INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF INFLAMMATION
申请人:Hammock D. Bruce
公开号:US20070117782A1
公开(公告)日:2007-05-24
The invention provides compounds that inhibit epoxide hydrolase in therapeutic applications for treating hypertension. A preferred class of compounds for practicing the invention have the structure shown by Formula 1
wherein Z is oxygen or sulfur, W is carbon phosphorous or sulfur, X and Y is each independently nitrogen, oxygen, or sulfur, and X can further be carbon, at least one of R
1
-R
4
is hydrogen, R
2
is hydrogen when X is nitrogen but is not present when X is sulfur or oxygen, R
4
is hydrogen when Y is nitrogen but is not present when Y is sulfur or oxygen, R
1
and R
3
is each independently C
1
-C
20
substituted or unsubstituted alkyl, cycloalkyl, aryl, acyl, or heterocyclic.
The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I), (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I)
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.